Search results
Results From The WOW.Com Content Network
Discover how Novartis turns breakthrough science into transformative, high-value treatments. Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Find information on our research locations and corporate offices around the world.
Novartis executes separation of the Sandoz business to create an independent company by way of a 100% Spin-off. Shares of Sandoz will be listed and commence trading today on the SIX Swiss...
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered...
Novartis is a pharmaceutical company based in Switzerland. Its portfolio is focused primarily on the areas of Immunology, Neuroscience, Oncology, Cardiovascular, Renal, and Metabolic therapies.
Novartis Pharma AG. Ad hoc announcement pursuant to Art. 53 LR. New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to...
Discover real-time Novartis AG Common Stock (NVS) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporation (collectively, Novartis) appeal from a Patent Trial and Appeal Board (Board) final written decision finding all claims of U.S. Patent No. 9,220,631 ('631 patent) unpatentable under 35 U.S.C. § 103.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.